EIDX - エイドス・セラピュ―ティクス (Eidos Therapeutics Inc.) エイドス・セラピュ―ティクス

 EIDXのチャート


 EIDXの企業情報

symbol EIDx
会社名 Eidos Therapeutics Inc (エイドス・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Eidos Therapeutics Inc. is a clinical stage biopharmaceutical company. The Company is focused on addressing the unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). It focuses on treating the disease by targeting them at their collective source by stabilizing TTR. The Company’s product candidate AG10 is an orally-administered small molecule designed to potently stabilize tetrameric TTR thereby halting at its outset the series of molecular events that give rise to ATTR. AG10 binds and stabilizes TTR in the blood preventing the formation of amyloid and halting progression of the disease.   エイドス・セラピュ―ティクスは米国のバイオ医薬品企業。臨床段階で、希少疾患に対する治療薬の開発・商業化に従事する。同社はトランスサイレチン(TTR)やアミドイロ―シス(ATTR)によって引き起こされる疾患に対する治療薬の開発に焦点を当てる。本社所在地はカリフォルニア州サンフランシスコ。   
本社所在地 101 Montgomery Street Suite 2550 San Francisco CA 94104 USA
代表者氏名 Jonathan C. Fox ジョナサン・フォックス
代表者役職名 President chief medical officer
電話番号 +1 650-391-9740
設立年月日 41487
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数
url www.eidostx.com
nasdaq_url https://www.nasdaq.com/symbol/eidx
adr_tso
EBITDA EBITDA(百万ドル) -25.32500
終値(lastsale) 10.05
時価総額(marketcap) 369357871.35
時価総額 時価総額(百万ドル) 358.33220
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 181.64320
当期純利益 当期純利益(百万ドル) -34.08400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Eidos Therapeutics Inc revenues was not reported. Net loss increased from $4.1M to $26.2M. Higher net loss reflects Research and development - Balan increase from $3.2M to $11.2M (expense) Loss on extinguishment of debt increase from $0K to $6.7M (expense) General and administrative increase from $831K to $3.9M (expense).

 EIDXのテクニカル分析


 EIDXのニュース

   Eidos Therapeutics Inc Shares Climb 3.2% Past Previous 52-Week High - Market Mover  2020/12/22 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 3.2% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 112.7% year-to-date, up 98.8% over the past 12 months, and up 427.9% over the past five years. This week, the Dow Jones Industrial Average rose 1.2%, and the S&P 500 rose 1.3%. Trading Activity Trading volume this week was 1.3% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.0% higher than its 20-day moving average, and 79.4% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -9.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 1.9% Past Previous 52-Week High - Market Mover  2020/12/21 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 1.9% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 108.6% year-to-date, up 95.0% over the past 12 months, and up 417.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 50.4% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 19.6% higher than its 20-day moving average, and 76.3% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -12.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 0.4% Past Previous 52-Week High - Market Mover  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Trading volume this week was 24.5% lower than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Close the Week 12.0% Higher - Weekly Wrap  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed the week 12.0% higher than it did at the end of last week. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $122.48 and as low as $109.24 this week. Shares closed 0.4% above its 52-week high and 2e+2% above its 52-week low. Trading volume this week was 38.4% lower than the 10-day average and 19.9% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 4.8% Past Previous 52-Week High - Market Mover  2020/12/17 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 4.8% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 98.0% year-to-date, up 73.1% over the past 12 months, and up 391.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 22.1% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.7% higher than its 20-day moving average, and 76.7% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -34.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 3.2% Past Previous 52-Week High - Market Mover  2020/12/22 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 3.2% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 112.7% year-to-date, up 98.8% over the past 12 months, and up 427.9% over the past five years. This week, the Dow Jones Industrial Average rose 1.2%, and the S&P 500 rose 1.3%. Trading Activity Trading volume this week was 1.3% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.0% higher than its 20-day moving average, and 79.4% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -9.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 1.9% Past Previous 52-Week High - Market Mover  2020/12/21 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 1.9% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 108.6% year-to-date, up 95.0% over the past 12 months, and up 417.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 50.4% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 19.6% higher than its 20-day moving average, and 76.3% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -12.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 0.4% Past Previous 52-Week High - Market Mover  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Trading volume this week was 24.5% lower than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Close the Week 12.0% Higher - Weekly Wrap  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed the week 12.0% higher than it did at the end of last week. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $122.48 and as low as $109.24 this week. Shares closed 0.4% above its 52-week high and 2e+2% above its 52-week low. Trading volume this week was 38.4% lower than the 10-day average and 19.9% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 4.8% Past Previous 52-Week High - Market Mover  2020/12/17 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 4.8% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 98.0% year-to-date, up 73.1% over the past 12 months, and up 391.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 22.1% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.7% higher than its 20-day moving average, and 76.7% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -34.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 3.2% Past Previous 52-Week High - Market Mover  2020/12/22 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 3.2% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 112.7% year-to-date, up 98.8% over the past 12 months, and up 427.9% over the past five years. This week, the Dow Jones Industrial Average rose 1.2%, and the S&P 500 rose 1.3%. Trading Activity Trading volume this week was 1.3% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.0% higher than its 20-day moving average, and 79.4% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -9.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 1.9% Past Previous 52-Week High - Market Mover  2020/12/21 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 1.9% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 108.6% year-to-date, up 95.0% over the past 12 months, and up 417.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 50.4% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 19.6% higher than its 20-day moving average, and 76.3% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -12.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 0.4% Past Previous 52-Week High - Market Mover  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Trading volume this week was 24.5% lower than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Close the Week 12.0% Higher - Weekly Wrap  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed the week 12.0% higher than it did at the end of last week. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $122.48 and as low as $109.24 this week. Shares closed 0.4% above its 52-week high and 2e+2% above its 52-week low. Trading volume this week was 38.4% lower than the 10-day average and 19.9% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 4.8% Past Previous 52-Week High - Market Mover  2020/12/17 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 4.8% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 98.0% year-to-date, up 73.1% over the past 12 months, and up 391.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 22.1% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.7% higher than its 20-day moving average, and 76.7% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -34.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 エイドス・セラピュ―ティクス EIDX Eidos Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)